This inventor holds 0 USPTO granted patents, plus 5 CIPO patents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Masato Okamoto: Innovator in NK Cell Amplification
Introduction
Masato Okamoto is a notable inventor from Japan, recognized for his contributions to the field of immunotherapy. His innovative work focuses on the amplification of natural killer (NK) cells, which are crucial for adoptive immunotherapy.
Latest Patents
Masato Okamoto currently holds 0 patents. However, he has developed a significant method for amplifying NK cells in vitro. This method involves preparing a cell population comprised of NK cells, removing T cells from this population, and cultivating the remaining cells in a medium supplemented with 2500 to 2831 IU/mL of IL-2. The invention also includes a pharmaceutical composition for adoptive immunotherapy, which comprises NK cells prepared by this amplifying method.
Career Highlights
Throughout his career, Masato Okamoto has worked with esteemed institutions such as Kyushu University and Gaia Biomedicine Inc. His research has contributed to advancements in immunotherapy techniques, particularly in enhancing the efficacy of NK cells.
Collaborations
Masato Okamoto has collaborated with notable colleagues, including Yoshikazu Yonemitsu and Yui Harada. Their combined efforts have furthered research in the field of cell therapy.
Conclusion
Masato Okamoto's innovative approach to NK cell amplification represents a significant advancement in the field of immunotherapy. His work continues to inspire future research and development in this critical area of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile